SCHEMBL1056700

SCHEMBL1056700

Cc1ccc(-c2cc(-c3cccc(C(N)=O)c3)no2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.62
RAB9A P51151 6/20 0.62
CASP3 P42574 1/20 0.62
SENP8 Q96LD8 1/20 0.62
SENP7 Q9BQF6 1/20 0.62
SENP6 Q9GZR1 1/20 0.62
RET P07949 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.50
TP53 P04637 2/20 0.50
MAPT P10636 1/20 0.50
CACNA1B Q00975 1/20 0.50
APBA1 Q02410 1/20 0.50
THRB P10828 1/20 0.49
DHODH Q02127 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
PARP1 P09874 1/20 0.47
MAP2K4 P45985 1/20 0.47
PTGS2 P35354 2/20 0.46
HSD17B1 P14061 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4876695 0.88 NPC1 (0.68) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL937517 0.84 NPC1 (0.59) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL12171608 0.84 NPC1 (0.67) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL6923851 0.81 PRKD1 (0.63) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL7452638 0.81 ADORA2A (0.47) NPC1RAB9ARETSMN1; SMN2TP53
SCHEMBL8094911 0.80 NPC1 (0.67) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL3727219 0.79 DHODH (0.71) DHODHPARP1MAP2K4
SCHEMBL12171576 0.79 NPC1 (0.56) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL11646186 0.78 NPC1 (1.00) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL12450538 0.78 NPC1 (1.00) NPC1RAB9ACASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011009484-A1 ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS NOVARTIS AG (CH) 2011-01-27 WO disclosed